Surface Oncology has appointed Theresa Boni as general counsel and senior vice president for legal.
Boni was previously vice president and assistant general counsel at Dicerna Pharmaceuticals, vice president and associate general counsel at Kiniksa Pharmaceuticals and before that held senior legal positions with Boston Scientific and Thermo Electron (now Thermo Fisher Scientific).
Outside of the life sciences company field, Boni has held senior legal positions with Houghton Mifflin Harcourt and investment firm Patriarch Partners. Earlier in her legal career, she was an attorney with Bingham McCutchen (now Morgan Lewis).
Nasdaq-listed Surface is a clinical-stage immuno-oncology company developing immunotherapies that target the tumor microenvironment.
Surface CEO Rob Ross says in a statement: ‘Teri is an impressive leader who brings deep legal and business acumen combined with a passion for improving the lives of patients, and we are delighted to welcome her to Surface.’
According to a company announcement, Boni succeeds Liisa Nogelo who has left Surface to pursue other opportunities. Ross adds in the announcement: ‘Liisa was an outstanding partner, and we are tremendously grateful for her service. We wish her continued success as she starts the next chapter of her career.’
Nogelo could not be reached immediately for comment.
Ben Maiden
Ben Maiden is the editor-at-large of Governance Intelligence, an IR Media publication, having joined the company in December 2016. He is based in New York. Ben was previously managing editor of Compliance Reporter, covering regulatory and compliance...
